12:00 AM
 | 
Mar 17, 1997
 |  BC Week In Review  |  Company News  |  Deals

Biorelease, TheraMed Partners Inc. deal

BREL's board terminated the company's planned acquisition of TheraMed (see BioCentury, Oct. 14, 1996). BREL will return the subscriptions of accredited...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >